Riskpilot← Back to searchSign inGet full accessDr Parisa AB
ABActiveOrg 5569850364Sjöviksvägen 23Medical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
SEK 1M
-6% vs 2024
EBITDA margin
34.5%
-3% vs 2024
Equity ratio
64.8%
Financial strength
Net profit 2025
SEK 280K
-4% vs 2024
| Revenue | SEK 1M | -6% |
| EBITDA | SEK 358K | -3% |
| Net profit | SEK 280K | -4% |
| Total assets | SEK 667K | +13% |
| Equity | SEK 432K | +8% |
| Employees | 1 | — |
Legal name
Dr Parisa AB
Org number
5569850364
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 oktober 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva tjänsteverksamhet inom sjukvårdsområdet och kosmetiskt relaterade behandlingar, äga och förvalta fast och lös egendom samt för egen räkning bedriva handel med värdepapper samt därmed förenlig verksamhet.
Address
Sjöviksvägen 23
Email
pierre@jwk.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 481 | 1 131 | 971 | 1 104 | 1 038 |
| Staff expenses | — | −790 | −483 | −571 | −428 |
| EBITDA | 787 | 132 | 377 | 370 | 358 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 787 | 132 | 377 | 370 | 358 |
| Net financials | — | 0 | 0 | −0 | −1 |
| Profit before tax | 786 | 132 | 378 | 369 | 357 |
| Tax | −129 | −34 | −80 | −78 | −77 |
| Net profit | 657 | 97 | 297 | 291 | 280 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 950 | 336 | 594 | 588 | 667 |
| Equity | 716 | 164 | 361 | 402 | 432 |
| Long-term debt | 12 | 15 | 0 | — | — |
| Short-term debt | 221 | 157 | 233 | 186 | 235 |
| Total debt | 233 | 172 | 233 | 186 | 235 |
EBITDA margin
34.5%
This company
15.8%
Market median
+118% vs market
20212025
Equity ratio
64.8%
This company
38.2%
Market median
+70% vs market
20212025
Return on equity
64.8%
This company
18.4%
Market median
+252% vs market
20212025
Net profit margin
27.0%
This company
8.1%
Market median
+233% vs market
20212025
Asset turnover
1.56×
This company
1.12×
Market median
+39% vs market
20212025
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Parisa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Parisa Ariapart | Board of Directors | 0 companies |
| Anna Diana Andacheh | Deputy Board Member | 0 companies |